Lupus y Embarazo
DOI:
https://doi.org/10.31053/1853.0605.v64.n4.25447Palabras clave:
lupus, embarazoResumen
.Descargas
Referencias
Donaldson LB. De Alvarez RR. Further ohservations ori lupus erythematosus associated with pregnancy. Am Obstel Gynecol 1962:83: 1461-73.
Ellis FA, Bereston ES. Lupus erythematosus associated with pregnancy and menopause. AMA Arch Dcrm Syphilol 1952,65:170-6.
Khamashl.a MA. Systernic lupus erythematosus ami pregnancy. Best Pract Res Clin Rheumatol 2006:20:685-94.
Cervera R, Font J, Carmona F, Balasch J. Pregnancy outcome in systemic lupus erythematosus : gcod news for the new millennium. Autoimmun Rey 2002:1: 354-9.
Boumpas UF, Austin HA, Vaughan EM et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy Ann lntern Med 1993; 119: 366-69.
Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: Ten qucstions and sorne answers. Lupus 2008;17;416-420.
Clowse MEB, Magder LS, Petri M. The irnpact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005; 52:514- 521.
Lima F, Khamashta MA, Buchanan NMM et al. A study of sixty pregnancies in patients with antiphospholipid syndrome. Clin ExpRheumatol 1996:14: 131-136.
Ramsey-Golclman R, Kutzer JE, Kuller LH, et al. Pregnancy outcome and anti-anticardiolipin antibody in women with systemic lupus eiyffiematosus. Am J Epidemiol 1993; 138: 1057-1069.
Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006; 15:148-155.
Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gyriecol 2003; 101: 1333-1344.
Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newboms ofmotherswith anti- Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001:44: 1832-1835
Cuadrado MJ Mendonca LLF, Khamashta MA et al. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum 1999; 42: S265.
Bonnin M, Mercier FJ, Sitbon O. et' al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: 1133-1137.
Me Millan E, Martin WL, Waugh J, et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and antiphospholipid syndrome. Lupus 2002; 11: 392-398.
Ostensen M, Khamashta MA, Lockshin M et al. Anti-inulammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006:8:209-227.
Ostensen M, Lockshin M. Doria A et al. lJpdate on safety during pregnancy of biological agents and sorne inimunosuppressive antirheumatic drugs. Rheumatology 2008:47:28-31.
Clowse MEB, Magder L, Witter F et al. Hydroxycloroquine in lupus pregnancy. Arthritis Rheum 2006:54: 3640-7,
Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy of antimalarlais in systemic lupus erythematosus: a systematic review. And Rheum Dis Dec 2008(Ahead of print). Buchanan NM, Toubi E, Khamashta MA et al. 1-lydroxicloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 1996:55:486-88.
Costedoat-Chalumeau N, Amoura Z. Duhaut P et al. Safety of hydroxycloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003:48: 3207-11.
Mintz G, Nitz J, Gutierrez G, et al. Prospective study ofpregnancy in systemic lupus erythematosus: results of a multi-disciplinary approach. J Rheumatol 1986;! 3:732-9.
Lockshin MD, Reinitz E, Druzin ML et al. Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893-8.
Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum 1.993;36:1392-97.
Petri M, Howard D, Repked. Frequency of lupus fiare in pregnancy: the Hopkins lupus pregnancy center experience. Arthritis Rheum 1991:34: 1538-45.
Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus fiare during pregnancy and puerperium. Br J Rheumatol 1996:35:133-8.
Worig KL, Chan F'Y, Lee XP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch InternMed 1991:151: 269-73.
Tandon A. Ibanez D, Gladman DD et al. The effect of pregnancy on lupus nephritis. Arthritis Rheum 2004:50:3941-6.
Levy RA, Vilela VS, Cataldo MJ et al. Hydroxycloroquine in lupus pregnancy: doubleblind and placebo -controlled study. Lupus .2001:10:401-4.
Cortes-Hernandez J, Ordi-Ros J, Paredes F et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 2002; 41: 643-650.
Khainashta MA, Ruiz-Irastorza G, Hughes GRV. Systernic lupus erythematosus fiares during pregnancy. Rheum Dis Clin North Am 1997: 23:15-30.
Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin N Am 2007; 33:27-35.
HayslettJP, Lynn Rl. Effect of pregnancy in patients with lupus nephropathy. Kidney mt 1980; 18:207-220.
Jungers P, Dougados M, Pelissler C et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Mcd 19821142:771-776.
Imbasciati E, Surian M, Bottino S et al. Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus eiyhternatosus and nephritis. Nephron 1984:36:46-51.
Packham DK, Lam SS, Nicholls K et al. Lupus nephritis and pregnartcy. Q J Mcd 1992; 83:315-324.
Julkunem H. Renal lupus in pregnancy. Scand J Rheumatol 1998:27: 80-83.
Huong DT, Wechsler B, Vauther- Brouzes D et al. Prcgnancy and its outcome in systemic lupus erythematosus. Q J Mcd 1994;87: 721-29.
Ovlasu E, E, Hicks J, Cameron ,JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991;l:19-25.
Moroni G, Quaglini S, Banfi G et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002:40:713-720.
Imbasciati E, Tincani A, Gregorini G et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2008: 1-7.
Zulman J, Tala N, Hoffman GS et al. Frobiems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol 1980:7: 37-49.
Bobrie G, Liote F, Houiller P et al. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987; 9:339-343.
Carmona F, Font J, Moga 1 et al. Class ¡II-TV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 2005:53:182..
Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus 2005:14:89-94.
Day Cd, Lipkin GW, Savage COS. Lupus nephritis and pregnancy in the 21 st centurv. Nephrol Dial Transplant 2009; 24: 344-47.
Mime F, Redman C, Waiker J et al. The preeclampsia community guideline (PRECOG): how to screen for and detect onset of precclampsia in the community. Br Mcd J 2005;330: 576-580.
Barton JR, Sibai BM. Precliction and prevention of recurrent preeclampsia. Obstet Gynecol 2008: 112:359-372.
Mackillop LII, Germain Si, Nelson- Piercy C, Hughes GRV. Effects of lupus and antiphospholipid syndrome on pregnancy. Yearh Obstel Gynecol 2002; 10: 105-119.
Askie LM, Duley L, Henderson-Smart DJ el al. PARIS Collaborative Group. Antiplatelet agents for prevention of preeclampsia: A metaanalysis of individual patient data. Lancet 2007; 369: 1791-8.
Love PE, Saritoro SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagularit in SLE and in non-SLE disorders. Ann Intern Med 1990; 112: 682-698.
Miyakis 5, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International Consensus statement on an update of the clasitication entena for definitive antiphospholipid syndrome. J Thromb Haemost 2006: 4 : 295-306.
Lima F. Buchanan NM, Khamashta MA et al. Obstetric outcome in systcmic lupus erythematosus. Seminars Arhtritis Rheum 1995: 25: 184-192.
Opatrny L, David M, Kahn SR, et al. Association hetween antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 2006; 33: 2214-21.
Derksen RH, Khamashta Ma, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004; 50:1028-1039.
Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriages for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rey 2005; 18(2):CD002859.
Petri M, Qazi U. Management of the antiphospholipid syndrome in pregnancy. Rheum Dis Clin N Am 2006:32: 59 1-607.
Ruiz Irastorza G, Khamashta MA. Antiphospholipid Syiidrome in pregnancy. Rheum Dis Clin N Am 2007;33:287-97. CarmonaF, FontJ,AzulayM, etal. RiskFactors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate análisis. Am J Reprod Immuno1 2001; 46: 274-9..
Ruiz Irastorza G, Khamashta MA, Hughes GRV. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rey 2002: 1:298-304.
Ruiz Irastorza G. Khamashta MA.Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Am NY Acad Se¡ 2005; 1051: 606-12.
Ruiz Irastorza G, Khamashta MA, Nelson-Piercy C et al. Lupus pregnancy: is hepann a risk factor for osteoporosis? Lupus 2001: 10:597-600.
Risk of congenital complete heart block in newboms ofrnothcrswlth anti-Ro/SSAaritibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001:44, 1832-35.
Gordon P. Khainashta MA, Rosenthal E et al. Anti-52 kDa Ro, anti-60 kDa Ro and ant! La antibody profiles in neonatal lupus. Journal of Rheumatology 2004:31: 2480-87.
Buyon JP, Hiebert R, Copel J et al. Autoimmune associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registrv. J Am Col] Cardiology 1998;31: 1658-66.
Saleeb S. Cope¡ J, Fnedman D et al. Comparison of treatrnent with fluorinated glucocorticoids to the national history of autoantibody-associated congenital heart block retrospective rev!ew of the research registiy for neonatal lupus. Arthritis Rheum 1999; 42:2335-45.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2019 Universidad Nacional de Córdoba
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Se permite la generación de obras derivadas siempre que no se haga con fines comerciales. Tampoco se puede utilizar la obra original con fines comerciales.